| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Cellular and Molecular Medicine*
and Ludwig Institute for Cancer Research,
University of California-San Diego, La Jolla, California
We have previously demonstrated that vascular endothelial growth factor-165 (VEGF), a tumor-secreted angiogenic factor, can acutely and chronically induce fenestrations in microvascular endothelium (Cancer Res 1997, 57:765–772). Because the morphology and function of microvascular endothelium differs from tissue to tissue, we undertook studies to examine whether the neovasculature in tumors also differed depending upon tumor location. Four tumor types implanted in the brain or subcutis in nude mice were studied: a murine rhabdomyosarcoma (M1S), a murine mammary carcinoma (EMT), and two human glioblastomas (U87 and U251). In addition, we studied Chinese hamster ovary cells stably transfected with human VEGF165. As previously reported, tumors grown in the subcutaneous space had a microvasculature that was fenestrated and had open endothelial gaps. The identical tumors when grown in the brain also had fenestrated endothelium and vessels with open endothelial gaps, but they were drastically reduced in occurrence. Open endothelial gaps were not seen in all tumors implanted in the brain (EMT and M1S), although fenestrated endothelium was always seen. VEGF and VEGF receptors were measured in tumors from both locations by immunoblotting and competitive polymerase chain reaction, respectively. VEGF amount was not significantly different between the tumor locations. Interestingly, total tumor vascular mRNA expression of both Flk-1 and Flt-1 was greater in tumor vessels derived from the brain compared with tumor vessels derived from subcutaneous tissues. These results demonstrate that the host microvascular environment determines the morphology and function of the tumor vasculature and that endothelia from different tissues vary in their ability to express the VEGF receptors given identical stimuli.
This article has been cited by other articles:
 |
|
 |
|
  P. Hoffmann, J.-J. Feige, and N. Alfaidy Expression and Oxygen Regulation of Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 and Its Receptors in Human Placenta during Early Pregnancy Endocrinology, April 1, 2006; 147(4): 1675 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sengoelge, W. Luo, D. Fine, A. M. Perschl, W. Fierlbeck, A. Haririan, J. Sorensson, T.-U. Rehman, P. Hauser, J. S. Trevick, et al. A SAGE-based comparison between glomerular and aortic endothelial cells Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1290 - F1300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Madden, B. P. Cook, M. Nacht, W. D. Weber, M. R. Callahan, Y. Jiang, M. R. Dufault, X. Zhang, W. Zhang, J. Walter-Yohrling, et al. Vascular Gene Expression in Nonneoplastic and Malignant Brain Am. J. Pathol., August 1, 2004; 165(2): 601 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Guo, B. Hu, W. Gu, L. Xu, D. Wang, H.-J. S. Huang, W. K. Cavenee, and S.-Y. Cheng Platelet-Derived Growth Factor-B Enhances Glioma Angiogenesis by Stimulating Vascular Endothelial Growth Factor Expression in Tumor Endothelia and by Promoting Pericyte Recruitment Am. J. Pathol., April 1, 2003; 162(4): 1083 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. LeCouter, R. Lin, M. Tejada, G. Frantz, F. Peale, K. J. Hillan, and N. Ferrara The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells PNAS, March 4, 2003; 100(5): 2685 - 2690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. L. Monsky, C. M. Carreira, Y. Tsuzuki, T. Gohongi, D. Fukumura, and R. K. Jain Role of Host Microenvironment in Angiogenesis and Microvascular Functions in Human Breast Cancer Xenografts: Mammary Fat Pad versus Cranial Tumors Clin. Cancer Res., April 1, 2002; 8(4): 1008 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Pfander, D Kortje, R Zimmermann, G Weseloh, T Kirsch, M Gesslein, T Cramer, and B Swoboda Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints Ann Rheum Dis, November 1, 2001; 60(11): 1070 - 1073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kunkel, U. Ulbricht, P. Bohlen, M. A. Brockmann, R. Fillbrandt, D. Stavrou, M. Westphal, and K. Lamszus Inhibition of Glioma Angiogenesis and Growth in Vivo by Systemic Treatment with a Monoclonal Antibody against Vascular Endothelial Growth Factor Receptor-2 Cancer Res., September 1, 2001; 61(18): 6624 - 6628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Harris, P. Reusch, B. Barleon, C. Hang, N. Dobbs, and D. Marme Soluble Tie2 and Flt1 Extracellular Domains in Serum of Patients with Renal Cancer and Response to Antiangiogenic Therapy Clin. Cancer Res., July 1, 2001; 7(7): 1992 - 1997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Dvorak and D. Feng The Vesiculo-Vacuolar Organelle (VVO): A New Endothelial Cell Permeability Organelle J. Histochem. Cytochem., April 1, 2001; 49(4): 419 - 432. [Abstract] [Full Text]
|
|
|
|
|
|
H. Hashizume, P. Baluk, S. Morikawa, J. W. McLean, G. Thurston, S. Roberge, R. K. Jain, and D. M. McDonald Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness Am. J. Pathol., April 1, 2000; 156(4): 1363 - 1380. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
